'Plasminogen' presentation slideshows

FIBRINOLYTIC THERAPY

FIBRINOLYTIC THERAPY. (Thrombolytic Therapy) . OBJECTIVES. Identify the indications for use in AMI Identify the indications for use in acute non-hemorrhagic stroke Have knowledge of patient selection criteria Have an enlarged scope of knowledge with regard to fibrinolytics. INTRODUCTION .

517 views • 34 slides

FIBRINOLYTIC THERAPY

FIBRINOLYTIC THERAPY. (Thrombolytic Therapy) . OBJECTIVES. Identify the indications for use in AMI Identify the indications for use in acute non-hemorrhagic stroke Have knowledge of patient selection criteria Have an enlarged scope of knowledge with regard to fibrinolytics. INTRODUCTION .

463 views • 34 slides

THROMBOLYTIC DRUGS (Fibrinolytic drugs) By Prof. Hanan Hagar Dr. Ishfaq Bukhari

THROMBOLYTIC DRUGS (Fibrinolytic drugs) By Prof. Hanan Hagar Dr. Ishfaq Bukhari. OBJECTIVES. To know mechanism of action of thrombolytic therapy. To differentiate between different types of thrombolytic drugs. To describe indications, side effects and contraindications of thrombolytic drugs.

533 views • 34 slides

THROMBOLYTIC DRUGS (Fibrinolytic drugs) By Prof. Hanan Hagar Dr. Ishfaq Bukhari

THROMBOLYTIC DRUGS (Fibrinolytic drugs) By Prof. Hanan Hagar Dr. Ishfaq Bukhari. OBJECTIVES. To know mechanism of action of thrombolytic therapy. To differentiate between different types of thrombolytic drugs. To describe Indications, side effects and contraindications of thrombolytic drugs.

1.44k views • 30 slides

THROMBOLYSIS Alteplase: Pharmacodynamics and Pharmacokinetics

THROMBOLYSIS Alteplase: Pharmacodynamics and Pharmacokinetics. Dr Kevin Reiling. Tissue Plasminogen Activator. Coagulation Factors. Fibrinolysis. Plasminogen. Fibrinogen. Plasmin. Fibrin. Coagulation and Fibrinolysis. Natural Regulatory Balance.

868 views • 24 slides

Tissue plasminogen activator is the first and only drug approved by the FDA in 1996 for the treatment of acute ischemic stroke.

89 views • 8 slides